Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea Study
- DOI
- 10.1038/s41598-025-34325-4
- Published
- 1
- Container
- Scientific Reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-025-34325-4,
title = {Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea Study},
author = {Jae Ryong Song and Un Chul Park and Christopher Seungkyu Lee and Jae Jin Cho and Jin Young Kim and Seung Chul Baek and Areum Jeong and Ashish Sharma and Jae Hui Kim and Min Sagong and Se Joon Woo and International Retina Biosimilar Study Group (Inter BIOS Group)},
year = {2026},
journal = {Scientific Reports},
doi = {10.1038/s41598-025-34325-4},
url = {https://doi.org/10.1038/s41598-025-34325-4}
}RIS
TY - JOUR TI - Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea Study AU - Jae Ryong Song AU - Un Chul Park AU - Christopher Seungkyu Lee AU - Jae Jin Cho AU - Jin Young Kim AU - Seung Chul Baek AU - Areum Jeong AU - Ashish Sharma AU - Jae Hui Kim AU - Min Sagong AU - Se Joon Woo AU - International Retina Biosimilar Study Group (Inter BIOS Group) PY - 2026 JO - Scientific Reports DO - 10.1038/s41598-025-34325-4 UR - https://doi.org/10.1038/s41598-025-34325-4 ER -
APA
Song, J. R., Park, U. C., Lee, C. S., Cho, J. J., Kim, J. Y., Baek, S. C., Jeong, A., Sharma, A., Kim, J. H., Sagong, M., Woo, S. J., & Group), I. R. B. S. G. (. B. (2026). Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea Study. Scientific Reports. https://doi.org/10.1038/s41598-025-34325-4
Source records
- doaj · retrieved 2026-09-27T00:22:16.998Z